XT
CODX

XTX Topco’s Co-Diagnostics CODX Stock Holding History

XTX Topco’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,595
Closed -$14.8K – 2474
2025
Q1 		$14.8K Buy
+1,595
New +$30.5K ﹤0.01% 2195
2024
Q2 		– Sell
-788
Closed -$26.5K – 1959
2024
Q1 		$26.5K Buy
788
+155
+24% +$5.62K ﹤0.01% 1578
2023
Q4 		$25.2K Sell
633
-92
-13% -$3.24K 0.01% 1337
2023
Q3 		$23.1K Buy
+725
New +$27.4K ﹤0.01% 1360
2022
Q4 		– Sell
-369
Closed -$36K – 1176
2022
Q3 		$36K Sell
369
-475
-56% -$66.4K 0.01% 1046
2022
Q2 		$142K Buy
+844
New +$128K 0.06% 553

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco's CODX Position: Q2 2025 in Review

XTX Topco sold out of Co-Diagnostics (CODX) in Q2 2025, closing a stake of 1,595 shares — an estimated $14.8K sold.

XTX Topco first reported a position in CODX in Q2 2022 and held it in 6 quarters. The position peaked at $142K in Q2 2022. 35 funds tracked by Wall St. Rank hold CODX as of Q2 2025.

  • XTX Topco reported no remaining Co-Diagnostics position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 1,595 Co-Diagnostics shares in Q2 2025, an estimated $14.8K.
  • XTX Topco first reported a position in Co-Diagnostics in Q2 2022 and held it in 6 quarters.
  • XTX Topco's Co-Diagnostics position peaked at $142K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.